Complications and survival associated with operative procedures in patients with unresectable pancreatic head adenocarcinoma

Journal of Surgical Oncology

Volumn 109, Issue 7, 2014, Pages 697-701

  Spanheimer, Philip M ^a   Cyr, Anthony R ^a   Liao, Junlin ^a   Johlin, Frederick C ^a   Hoshi, Hisakazu ^a   Howe, James R ^a   Mezhir, James J ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

double bypass; metastasis; palliation; pancreatic cancer; unresectable disease

Indexed keywords

ABDOMINAL ABSCESS; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; BILE DUCT BYPASS; CANCER PALLIATIVE THERAPY; CANCER SURGERY; CANCER SURVIVAL; CEREBROVASCULAR ACCIDENT; CHOLECYSTECTOMY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEEP VEIN THROMBOSIS; DELIRIUM; ENDOSCOPIC SURGERY; FEMALE; GASTROJEJUNOSTOMY; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; ILEUS; INTESTINE OBSTRUCTION; LAPAROTOMY; LENGTH OF STAY; MALE; METASTASIS; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PEROPERATIVE COMPLICATION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEPSIS; STOMACH PARESIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME; URINARY TRACT INFECTION; VERY ELDERLY; WOUND INFECTION;

DOUBLE BYPASS; METASTASIS; PALLIATION; PANCREATIC CANCER; UNRESECTABLE DISEASE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PANCREATIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 84899547447     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23560     Document Type: Article

References (33)

1. Conroy T, Desseigne F, Ychou M, et al.: FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817-1825.
2. Brescia FJ,: Palliative care in pancreatic cancer. Cancer Control 2004; 11: 39-45.
3. el-Kamar FG, Grossbard ML, Kozuch PS,: Metastatic pancreatic cancer: Emerging strategies in chemotherapy and palliative care. Oncologist 2003; 8: 18-34.
4. Prokesch RW, Chow LC, Beaulieu CF, et al.: Local staging of pancreatic carcinoma with multi-detector row CT: Use of curved planar reformations initial experience. Radiology 2002; 225: 759-765.
5. Sarr MG, Cameron JL,: Surgical palliation of unresectable carcinoma of the pancreas. World J Surg 1984; 8: 906-918.
6. Lillemoe KD, Cameron JL, Hardacre JM, et al.: Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999; 230: 322-328, discussion 328-330.
7. Watanapa P, Williamson RC,: Surgical palliation for pancreatic cancer: Developments during the past two decades. Br J Surg 1992; 79: 8-20.
8. Espat NJ, Brennan MF, Conlon KC,: Patients with laparoscopically staged unresectable pancreatic adenocarcinoma do not require subsequent surgical biliary or gastric bypass. J Am Coll Surg 1999; 188: 649-655, discussion 655-647.
9. Lyons JM, Karkar A, Correa-Gallego CC, et al.: Operative procedures for unresectable pancreatic cancer: Does operative bypass decrease requirements for postoperative procedures and in-hospital days ? HPB 2012; 14: 469-475.
10. Ausania F, Vallance AE, Manas DM, et al.: Double bypass for inoperable pancreatic malignancy at laparotomy: Postoperative complications and long-term outcome. Ann R Coll Surg Engl 2012; 94: 563-568.
11. Kneuertz PJ, Cunningham SC, Cameron JL, et al.: Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: Trends and lessons learned from a large, single institution experience. J Gastrointest Surg 2011; 15: 1917-1927.
12. de Rooij PD, Rogatko A, Brennan MF,: Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg 1991; 78: 1053-1058.
13. Katsinelos P, Kountouras J, Germanidis G, et al.: Sequential or simultaneous placement of self-expandable metallic stents for palliation of malignant biliary and duodenal obstruction due to unresectable pancreatic head carcinoma. Surg Laparosc Endosc Percutan Tech 2010; 20: 410-415.
14. Kaw M, Singh S, Gagneja H,: Clinical outcome of simultaneous self-expandable metal stents for palliation of malignant biliary and duodenal obstruction. Surg Endosc 2003; 17: 457-461.
15. Garcea G, Ong SL, Dennison AR, et al. Palliation of malignant obstructive jaundice. Dig Dis Sci 2009; 54: 1184-1198.
16. George C, Byass OR, Cast JE,. Interventional radiology in the management of malignant biliary obstruction. World J Gastrointest Oncol 2010; 2: 146-150.
17. Van Heek NT, De Castro SM, van Eijck CH, et al.: The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: A prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 2003; 238: 894-902. discussion 902-895.
18. House MG, Choti MA,: Palliative therapy for pancreatic/biliary cancer. Surg Clin North Am 2005; 85: 359-371.
19. Mann CD, Thomasset SC, Johnson NA, et al.: Combined biliary and gastric bypass procedures as effective palliation for unresectable malignant disease. ANZ J Surg 2009; 79: 471-475.
20. Suk KT, Kim HS, Kim JW, et al.: Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction. Gastrointest Endosc 2006; 64: 522-529.
21. Siddiqui AA, Mehendiratta V, Loren D, et al.: Self-expanding metal stents (SEMS) for preoperative biliary decompression in patients with resectable and borderline-resectable pancreatic cancer: Outcomes in 241 patients. Dig Dis Sci 2013; 58: 1744-1750.
22. Shepherd HA, Royle G, Ross AP, et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: A randomized trial. Br J Surg 1988; 75: 1166-1168.
23. Moss AC, Morris E, Mac Mathuna P,. Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev 2006; CD004200.
24. Cheng HT, Tsou YK, Lin CH, et al.: Endoscopic metal stents for the palliation of malignant upper gastroduodenal obstruction. Hepatogastroenterology 2011; 58: 1998-2002.
25. van Hooft JE, Uitdehaag MJ, Bruno MJ, et al.: Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): A prospective multicenter study. Gastrointest Endosc 2009; 69: 1059-1066.
26. Toyama Y, Yoshida S, Saito R, et al.: Successful adjuvant bi-weekly gemcitabine chemotherapy for pancreatic cancer without impairing patients' quality of life. World J Surg Oncol 2013; 11: 3.
27. Sullivan KM, Kozuch PS,: Chemotherapy and other supportive modalities in the palliative setting for pancreatic cancer. Cancer J 2012; 18: 633-641.
28. Ciliberto D, Botta C, Correale P, et al.: Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A meta-analysis of randomised trials. Eur J Cancer 2012.
29. Maithel SK, Maloney S, Winston C, et al.: Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma. Ann Surg Oncol 2008; 15: 3512-3520.
30. White R, Winston C, Gonen M, et al.: Current utility of staging laparoscopy for pancreatic and peripancreatic neoplasms. J Am Coll Surg 2008; 206: 445-450.
31. Glant JA, Waters JA, House MG, et al.: Does the interval from imaging to operation affect the rate of unanticipated metastasis encountered during operation for pancreatic adenocarcinoma ? Surgery 2011; 150: 607-616.
32. Lafemina J, Chou JF, Gonen M, et al.: Hepatic arterial nodal metastases in pancreatic cancer: Is this the node of importance ? J Gastrointest Surg 2013; 17: 1092-1097.
33. Worni M, Castleberry AW, Clary BM, et al.: Concomitant vascular reconstruction during pancreatectomy for malignant disease: A propensity score-adjusted, population-based trend analysis involving 10 206 patients. Arch Surg 2012; 1-8.